Nattero G, Agostoni A, Brandi G, Cottino A, Gai V, Gastaldi L, Lisino F
Minerva Med. 1976 Jun 23;67(31):1999-2006.
This work is an attempt to find an answer to the question: once arrived at the diagnostic identification of a certain type of idiopathic headache, which treatment should be followed? On the basis of recent researches and experience acquired during ten years' activity of our Headache Unit, a diagnostic identification can be made for migraine (in all its types and evolution stages), cluster headache, tension headache and pure psycogenic headache. Among the most widely used drugs, positive pharmacological results were obtained with: cyproheptadine, pizotifen, cinnarizine, lysergic acid derivatives, histamine, reserpine, clonidine and a barbituric acid derivative. The therapeutic cycles were standardized, for each drug, in the way of administration, dosage and total duration of the treatment. A comparison between the data obtained and the pre-therapeutic situation was made. When repeated, the most efficacious therapeutic cycle was evaluated. According to Pearson's dispersion index, each group of patients improved respresents 16.68% of the expected total results (frequency of attacks reduced to 50%, 25% and 0%): for cyproheptadine, pizotifen, methysergide, histamine, clonidine and allil-propyl-malonylurea, the "p" is less than 0.001; for cinnarizine, less than 0.02. This "a posteriori" analysis does not take into account the placebo control, the "anticipation effect", and the "carry over effect". It cannot therefore be a comparison of efficacy among the various drugs. An evaluation based on "among patients" and "inside patient" method by means of the cross over system, can instead give some useful suggestion about which treatment is to be recommended to patients suffering from recurrent headaches. With regard to migraine sufferers: cinnarizine, cyproheptadine, clonidine, histamine, pizotifen und reserpine. For cluster headaches: cinnarizine, cyproheptadine, clonidine, histamine and reserpine. For tension headaches: cyproheptadine. For pure psychogenic headache: allyl-propyl-malonylurea. For migraine attacks or parossystic crises in the course of ondulating or continuous headaches, positive therapeutic results, statistically significant, were obtained with an association of indomethacin, caffeine and prochlorperazine.
一旦确诊某种类型的特发性头痛,应采取何种治疗方法?基于我们头痛治疗单元十年活动中获得的最新研究和经验,可对偏头痛(所有类型及其演变阶段)、丛集性头痛、紧张性头痛和单纯心因性头痛进行诊断。在最常用的药物中,使用以下药物获得了积极的药理学结果:赛庚啶、苯噻啶、桂利嗪、麦角酸衍生物、组胺、利血平、可乐定和一种巴比妥酸衍生物。针对每种药物,在给药方式、剂量和治疗总时长方面对治疗周期进行了标准化。对获得的数据与治疗前的情况进行了比较。重复进行时,评估了最有效的治疗周期。根据皮尔逊离散指数,每组病情改善的患者占预期总结果的16.68%(发作频率降至50%、25%和0%):对于赛庚啶、苯噻啶、甲基麦角新碱、组胺、可乐定和丙戊巴比妥,“p”小于0.001;对于桂利嗪,小于0.02。这种“事后”分析未考虑安慰剂对照、“预期效应”和“延续效应”。因此,它不能作为各种药物疗效的比较。通过交叉系统基于“患者间”和“患者内”方法进行的评估,反而可以为向复发性头痛患者推荐何种治疗提供一些有用的建议。对于偏头痛患者:桂利嗪、赛庚啶、可乐定、组胺、苯噻啶和利血平。对于丛集性头痛:桂利嗪、赛庚啶、可乐定、组胺和利血平。对于紧张性头痛:赛庚啶。对于单纯心因性头痛:丙戊巴比妥。对于波动性或持续性头痛过程中的偏头痛发作或阵发性危机,吲哚美辛、咖啡因和氯丙嗪联合使用取得了具有统计学意义的积极治疗效果。